Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.
about
Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemiaGenetic markers and biomarkers for age-related macular degeneration.Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.Homocysteine.Total homocysteine and cardiovascular disease.Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease.Lipoprotein (a) and strokeHomocysteine: an emergent cardiovascular risk factor?Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.High Lipoprotein(a) Levels are Associated With Long-Term Adverse Outcomes in Acute Myocardial Infarction Patients in High Killip Classes.Roles of homocysteine in cell metabolism: old and new functions.Lipoprotein(a): an emerging cardiovascular risk factor.Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus.Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease.Molecular targeting by homocysteine: a mechanism for vascular pathogenesis.Venous thrombosis associated with pernicious anaemia. A report of two cases and review.Effects of folic acid supplementation on serum homocysteine and lipoprotein (a) levels during pregnancy.Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID)Lipoprotein(a), homocysteine, and retinal arteriosclerosis.Risk factors for ischaemic stroke.Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Endothelial dysfunction: the link between homocysteine and hydrogen sulfide.Lipoprotein(a): searching for a function.Alpha 2-macroglobulin. A multifunctional binding and targeting protein with possible roles in immunity and autoimmunity.Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.Lipoprotein(a) in health and disease.The effects of oral vitamin supplementation on cardiovascular risk factors.Genes, greens, and homocysteine.Homocysteine activates platelets in vitro.Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens.Is homocysteine a causal and treatable risk factor for vascular diseases of the brain (cognitive impairment and stroke)?[Homocysteine and neuropsychiatric disorders].Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis.Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration.The effects of lipoprotein(a) and homocysteine on prognosis and risk factors in acute ischemic stroke.The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population.Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia.
P2860
Q28506932-7C36A857-8D48-4F56-9BEF-4F6A67C5CFFEQ33301643-65D8DDF6-F83F-442D-9523-315E4A07AEF2Q33306319-FE6D2F4D-C624-463D-AD07-59C63311369AQ33732664-19BF230D-B31F-41F1-A075-406368EC6063Q33785883-B55D0F02-E69B-44BE-8632-259136C6A4A5Q33791523-19F88611-7B06-400C-A14A-CC77E713F792Q34015050-0429DFB1-2BD9-4254-8542-D7458F3AE500Q34039985-9D706127-4415-484D-85CB-820A04D901BBQ34075182-A381A7A0-1E90-42EC-A9E5-0FEE7DFFDEBDQ34297896-4079A869-B06E-4BE4-93A1-0D408F3D73AFQ34308857-B7BE6106-0C82-438C-94E2-F8E59915E8F3Q35081894-6D85D7AF-C19F-4551-926A-C8AD664FC015Q35643684-1298C27A-3BA1-40E9-A786-7DD60C9981EFQ36263853-4B92B4C2-1AC3-4E67-9698-1830E0025789Q36273339-9F138DDF-A62C-4945-B47F-EE1EDACC5B57Q36497387-DA0F3121-F492-450F-9F1F-9D3B6FEEC8A9Q36626392-91C3B584-F2DD-46CC-AE7C-7F7E9874ABE3Q36768001-803117C3-4933-4983-B4BF-A2800D27B70AQ36881908-48E729A5-0930-488D-86D8-A44175600356Q37244553-F707F651-BB1C-4DF6-A5A8-A47A1F094876Q37370315-37DE7979-1C98-48C9-9A8F-13F3EE08580AQ37995534-F78E601D-CFFC-48A9-BBA7-3A13492720CCQ38227415-BF2343B6-1B50-43B7-A0B0-55CD2A0E4884Q38297789-F626AB8E-DB21-4E57-AEFD-F7AF4F99529FQ40393749-8760583D-6B8C-41F9-B951-8BFA7378655DQ41208237-79B6F6B5-4803-497F-BB68-E585103AB6D3Q41300659-BDD8AA17-F958-4822-9585-B1202DDFA089Q41486362-76566837-DB96-44BA-98D3-B73AE6273ACDQ42391435-A065A4A7-0009-4A63-9918-C3FFFEB46A44Q42523086-8106938F-26C4-47BB-ADF5-F6CCECA480EAQ42845610-BEEC53D7-4B86-4F23-973F-47F83D8D4CCEQ43772989-38FBE549-AC2E-4011-808B-4379C77F1459Q43916603-9C044CD6-A9CD-47D7-B9E3-7B4BB755BD0CQ44825250-82E546C8-C384-441A-B7EA-C4523CFC5A9EQ46394738-B28F0F74-8BEA-4085-B3D0-35DCCC3DCF8AQ46415528-9CBA2795-F0E0-412F-944B-1FECD459BF08Q48175139-BE7E7F75-F511-4DA0-80FA-D5B29D892E5EQ48831348-4A6AA834-264D-4149-93C0-5FFE3AF43B23Q54178663-21FC666B-952A-42C0-8C92-2962FC04224B
P2860
Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Homocysteine and other sulfhyd ...... ulfhydryl compound metabolism.
@en
Homocysteine and other sulfhyd ...... ulfhydryl compound metabolism.
@nl
type
label
Homocysteine and other sulfhyd ...... ulfhydryl compound metabolism.
@en
Homocysteine and other sulfhyd ...... ulfhydryl compound metabolism.
@nl
prefLabel
Homocysteine and other sulfhyd ...... ulfhydryl compound metabolism.
@en
Homocysteine and other sulfhyd ...... ulfhydryl compound metabolism.
@nl
P2093
P2860
P921
P356
P1476
Homocysteine and other sulfhyd ...... ulfhydryl compound metabolism.
@en
P2093
P2860
P304
10193-10197
P356
10.1073/PNAS.89.21.10193
P407
P577
1992-11-01T00:00:00Z